RARLENCI Trademark

Trademark Overview


On Thursday, March 5, 2020, a trademark application was filed for RARLENCI with the United States Patent and Trademark Office. The USPTO has given the RARLENCI trademark a serial number of 88823355. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 26, 2022. This trademark is owned by Gilead Sciences Ireland UC. The RARLENCI trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
rarlenci

General Information


Serial Number88823355
Word MarkRARLENCI
Filing DateThursday, March 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 29, 2020

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Trademark Events


Event DateEvent Description
Tuesday, December 27, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 15, 2022SOU EXTENSION 3 GRANTED
Friday, April 15, 2022SOU EXTENSION 3 FILED
Friday, April 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 10, 2021ASSIGNED TO EXAMINER
Friday, October 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 6, 2021SOU EXTENSION 2 GRANTED
Wednesday, October 6, 2021SOU EXTENSION 2 FILED
Wednesday, October 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 31, 2021SOU EXTENSION 1 GRANTED
Wednesday, March 31, 2021SOU EXTENSION 1 FILED
Wednesday, March 31, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 7, 2020ASSIGNED TO LIE
Wednesday, July 22, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION E-MAILED
Thursday, May 28, 2020NON-FINAL ACTION WRITTEN
Sunday, May 24, 2020ASSIGNED TO EXAMINER
Wednesday, March 11, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 9, 2020NEW APPLICATION ENTERED